TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $207,000 | -13.4% | 15,197 | +6.9% | 0.06% | +4.8% |
| Q2 2021 | $239,000 | -60.0% | 14,222 | -56.6% | 0.06% | -55.1% |
| Q1 2021 | $598,000 | +78.0% | 32,737 | +77.6% | 0.14% | +56.8% |
| Q4 2020 | $336,000 | +41.8% | 18,437 | +38.7% | 0.09% | +51.7% |
| Q3 2020 | $237,000 | -23.1% | 13,295 | -34.4% | 0.06% | -13.4% |
| Q1 2020 | $308,000 | – | 20,282 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |